Andrew Hill

senior visiting Research Fellow in the Department of Molecular and Clinical Pharmacology at the University of Liverpool (England)

ResearchGate profile: https://www.researchgate.net/profile/Andrew-Hill

Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19
Systematic Review and Meta-Analysis of Ivermectin Safety Profile in COVID-19 Trials
Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud
Expression of Concern: “Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection”
Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection

https://c19ivermectin.com/hill.html

A paper authored by Kristian Thorlund, Kyle Sheldrick, Gideon Meyerowitz-Katz, Sonal Singh, and Hill critiqued the MOVe-OUT clinical trial studying molnupiravir.¹⁾

Ivermectin meta-analysis by Dr. Andrew Hill EXTENDED Jan 20, 2021